Li Yi Kui - Net Worth and Insider Trading

Li Yi Kui Net Worth

The estimated net worth of Li Yi Kui is at least $120 Million dollars as of 2024-06-22. Li Yi Kui is the Director of Tonghua Dongbao Pharmaceutical Co Ltd and owns about 13,594,295 shares of Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) stock worth over $120 Million. Details can be seen in Li Yi Kui's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Li Yi Kui has not made any transactions after 2018-05-24 and currently still holds the listed stock(s).

Transaction Summary of Li Yi Kui

To

Li Yi Kui Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Li Yi Kui owns 1 companies in total, including Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) .

Click here to see the complete history of Li Yi Kui’s form 4 insider trades.

Insider Ownership Summary of Li Yi Kui

Ticker Comapny Transaction Date Type of Owner
SHSE:600867 Tonghua Dongbao Pharmaceutical Co Ltd 2018-05-24 Director

Li Yi Kui Latest Holdings Summary

Li Yi Kui currently owns a total of 1 stock. Li Yi Kui owns 13,594,295 shares of Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) as of May 24, 2018, with a value of $120 Million.

Latest Holdings of Li Yi Kui

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SHSE:600867 Tonghua Dongbao Pharmaceutical Co Ltd 2018-05-24 13,594,295 8.85 120,309,511

Holding Weightings of Li Yi Kui


Li Yi Kui Form 4 Trading Tracker

According to the SEC Form 4 filings, Li Yi Kui has made a total of 0 transactions in Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) over the past 5 years. The most-recent trade in Tonghua Dongbao Pharmaceutical Co Ltd is the sale of 2,265,716 shares on May 24, 2018, which brought Li Yi Kui around $0.

Insider Trading History of Li Yi Kui

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Li Yi Kui Trading Performance

GuruFocus tracks the stock performance after each of Li Yi Kui's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Li Yi Kui is 13.42%. GuruFocus also compares Li Yi Kui's trading performance to market benchmark return within the same time period. The performance of stocks bought by Li Yi Kui within 3 months outperforms 10 times out of 14 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Li Yi Kui's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Li Yi Kui

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
8 out of 14 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.71 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 6.7 LIMIT LIMIT LIMIT LIMIT LIMIT

Li Yi Kui Ownership Network

Ownership Network List of Li Yi Kui

No Data

Ownership Network Relation of Li Yi Kui

Insider Network Chart

Li Yi Kui Owned Company Details

What does Tonghua Dongbao Pharmaceutical Co Ltd do?

Who are the key executives at Tonghua Dongbao Pharmaceutical Co Ltd?

Li Yi Kui is the Director of Tonghua Dongbao Pharmaceutical Co Ltd. Other key executives at Tonghua Dongbao Pharmaceutical Co Ltd include Supervisors Cheng Jian Qiu , senior management Chen Hong , and Supervisors Wang Dian Duo .

Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Tonghua Dongbao Pharmaceutical Co Ltd Insider Transactions

No Available Data

Li Yi Kui Mailing Address

Above is the net worth, insider trading, and ownership report for Li Yi Kui. Currently GuruFocus does not have mailing address information for Li Yi Kui.

Discussions on Li Yi Kui

No discussions yet.